Strength Seen in Cerus (CERS): Stock Gains 5.5% – Tale of the Tape

November 14, 2014 Technicals 0

Zacks

Cerus Corporation (CERS) was a big mover last session with its shares rising nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the volatile price range of $3.92 to $4.32 in the past one-month time frame.

This biomedical products company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cerus currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked stocks worth considering in the medical products industry are GW Pharmaceuticals plc (GWPH), OraSure Technologies, Inc. (OSUR) and Abaxis, Inc. (ABAX). While GW Pharmaceuticals and OraSure sport a Zacks Rank #1 (Strong Buy), Abaxis carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply